Ulipristal acetate
Cat. No.:YN481544
产品名称: | Ulipristal acetate |
CAS No.: | 126784-99-4 |
Chemical Name: | 17-(acetyloxy)-11β-[4-(dimethylamino)phenyl]-19-norpregna-4,9-diene-3,20-dione |
Synonyms: | 醋酸乌利司他; CDB-2914 |
分子量: | 475.62 |
分子式: | C₃₀H₃₇NO₄ |
SMILES: | O=C1CCC2=C3[C@@H](C4=CC=C(N(C)C)C=C4)C[C@@]5(C)[C@](CC[C@]5(OC(C)=O)C(C)=O)([H])[C@]3([H])CCC2=C1 |
存储: | Please store the product under the recommended conditions in theCertificate of Analysis. |
运输: | Room temperature in continental US; may vary elsewhere. |
产品描述: | Ulipristal acetate (CDB-2914) 是一种口服活性的选择性孕酮受体 (progesterone receptor) 调节剂 (SPRM)。Ulipristal acetate 选择性地刺激平滑肌瘤细胞的自噬反应。Ulipristal acetate 具有用于良性妇科疾病的潜力,如子宫肌瘤。 |
IC50和靶点: | |
In Vitro: | |
In Vivo: | |
Clinical Trial: | |
Solvent & Solubility: |
Attardi, B.J., Burgenson, J., Hild, S.A., et al.In vitro antiprogestational/antiglucocorticoid activity and progestin and glucocorticoid receptor binding of the putative metabolites and synthetic derivatives of CDB-2914, CDB-4124, and mifepristoneJ. Steroid Biochem. Mol. Biol.88(3),277-288(2004)
Gamarra-Luques, C.D., Hapon, M.B., Goyeneche, A., et al.Resistance to cisplatin and paclitaxel does not affect the sensitivity of human ovarian cancer cells to antiprogestin-induced cytotoxicityJ. Ovarian Res.7:45,(2014)
Communcal, L., Vilasco, M., Hugon-Rodin, J., et al.Proliferation and ovarian hormone signaling are impaired in normal breast tissues from women with BRCA1 mutations: Benefit of a progesterone receptor modulator treatment as a breast cancer preventive strategy in women with inherited BRCA1 mutationsOncotarget7(29),45317-45330(2016)
Nallasamy, S., Kim, J., Sitruk-Ware, R., et al.Ulipristal blocks ovulation by inhibiting progesterone receptor-dependent pathways intrinsic to the ovaryReprod. Sci.20(4),371-381(2013)